PATH TO REGULATORY REVIEW OF A QUANTITATIVE SYSTEM PHARMACOLOGY (QSP) MODEL

被引：0
|
作者：
Liu, G. [1 ]
Yang, Y. [1 ]
Zhu, H. [1 ]
机构：
[1] US FDA, Silver Spring, MD USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
LB-023
引用
收藏
页码：S34 / S34
页数：1
相关论文
共 50 条
  • [21] Integrating Lifestyle Factors In A Quantitative Systems Pharmacology (Qsp) Model Of Human Metabolism To Predict Long Term Cardiovascular Disease Risk
    Venkatapurapu, Sai Phanindra
    Matthew, Chezev
    Aggarwal, Abhinav
    Dwivedi, Gaurav
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S88 - S89
  • [22] A QUANTITATIVE SYSTEMS PHARMACOLOGY (QSP) MODEL FOR PRECLINICAL TO CLINICAL TRANSLATION OF ANTIBODY-DRUG CONJUGATE (ADC) EFFICACY AND THROM BOCYTOPENIA
    McGirr, K.
    Ghusinga, K.
    Gruver, S.
    Betts, A.
    Hua, F.
    Apgar, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S119 - S119
  • [23] Utilizing quantitative systems pharmacology (QSP) model to understand cytokine release syndrome (CRS) following administration of epcoritamab in DLBCL patients
    Afzal, Nasrin
    Li, Tommy
    Chiu, Christopher
    Sacchi, Mariana
    Gupta, Manish
    Xu, Steven
    Thalhauser, Craig J.
    CANCER RESEARCH, 2023, 83 (07)
  • [24] VISUALIZING PARAMETER SOURCE RELIABILITY AND GLOBAL SENSITIVITY FOR QUANTITATIVE SYSTEMS PHARMACOLOGY (QSP) MODELS.
    Braakman, S.
    Gulati, A.
    Tannenbaum, S.
    Paxson, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S75 - S75
  • [25] A Quantitative Systems Pharmacology (QSP) Approach to Understand the Pathogenesis of Acne and to Evaluate New Acne Therapies
    Bansal, Loveleena
    Wilde, Tom
    Gupta, Akanksha
    Kang, Grace
    Frey, Steve
    Hussey, Betty
    Damian-Iordache, Valeriu
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S22 - S23
  • [26] Quantitative Systems Pharmacology: A Regulatory Perspective on Translation
    Zineh, Issam
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2019, 8 (06): : 336 - 339
  • [27] QUANTITATIVE SYSTEMS PHARMACOLOGY (QSP) MODEL PREDICTS LACK OF EFFICACY FOR CENICRIVIROC, A CCR2/5 ANTAGONIST, IN NAFLD/NASH PATIENTS
    Battista, Christina
    Shoda, Lisl
    Siler, Scott Q.
    Generaux, Grant
    HEPATOLOGY, 2021, 74 : 1149A - 1150A
  • [28] A Quantitative Systems Pharmacology (QSP) Model to Compare the Non-Clinical Biodistribution and Efficacy between Recombinant Factor IX (rIX) Therapies
    Pestel, Sabine
    Chung, Douglas
    Rezvani-Sharif, Alireza
    Muir, Ineke
    Krupa, Sivarmurthy
    Brechmann, Markus
    Verhagan, Anne
    Dower, Steve
    van der Graaf, Piet H.
    Herzog, Eva
    Ghobrial, Oliver
    BLOOD, 2021, 138
  • [29] Integrated quantitative systems pharmacology (QSP) model of lysosomal diseases provides an innovative computational platform to support research and therapeutic development for the sphingolipidoses
    Kaddi, Chanchala
    Reali, Federico
    Marchetti, Luca
    Niesner, Bradley
    Parolo, Silvia
    Simoni, Giulia
    Zaph, Susana
    Tao, Mengdi
    Abrams, Ruth
    van Rijn, Zachary
    Leonard, John
    Peterschmitt, M. Judith
    Puga, Ana Cristina
    Mange, Kevin
    Barrett, Jeffrey S.
    Priami, Corrado
    Schuchman, Edward H.
    Azer, Karim
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S73 - S74
  • [30] A quantitative systems pharmacology (QSP) model to compare the non-clinical biodistribution and efficacy between recombinant factor IX (rIX) therapies
    Pestel, Sabine
    Chung, Douglas
    Rezvani-Sharif, Alireza
    Muir, Ineke
    Sivamurthy, Krupa
    Brechmann, Markus
    Verhagen, Anne
    Dower, Steve
    van der Graaf, Piet
    Herzog, Eva
    Ghobrial, Oliver
    HAEMOPHILIA, 2022, 28 : 7 - 7
12345